Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis | Zendy

Deepshikha Mishra | Zendy; Sunita Singh | Zendy; Gopeshwar Narayan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis

Author(s) -

Deepshikha Mishra,

Sunita Singh,

Gopeshwar Narayan

Publication year - 2016

Publication title -

molecular biology international

Language(s) - English

Resource type - Journals

eISSN - 2090-2190

pISSN - 2090-2182

DOI - 10.1155/2016/4328697

Subject(s) - carcinogenesis , medicine , cancer , cancer research , angiogenesis , tumor progression , transmembrane protein , tumor marker , antigen , cell , oncology , immunology , biology , genetics , receptor

The human CD10 antigen is a single pass, type II transmembrane, 100 kD cell surface glycoprotein belonging to peptidase M13 family. Identified in common acute lymphoblastic leukemia as a cancer specific antigen, CD10 is a cell surface ectoenzyme widely expressed on different types of cells. Earlier, it was used only as a cell surface marker to identify and differentiate between haematological malignancies. Later, reported to be present in various malignancies, it is thought to play significant role in cancer development and progression. Regulated expression of CD10 is necessary for angiogenesis and so forth. However its expression level is found to be deregulated in different cancers. In some cancers, it acts as tumor suppressor and inhibits tumor progression whereas in others it has tumor promoting tendency. However, its role in tumorigenesis remains unclear. This review summarises structural features, functions, and probable role of CD10 in cancer development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research